OTTBD News Items

12/13/11
Foundation Venture Capital Group a Model for Other Universities
Foundation Venture Capital Group (FVCG), an affiliate of the Foundation of UMDNJ/New Jersey Health Foundation, is the focus of the lead article in the most recent edition of the newsletter Technology Transfer Tactics/. The article describes how administrators at the University of Michigan decided to use money from their $7.8 billion endowment to fund start-up companies and turned to FVCG for advice. FVCG, which has become a model for other universities, works closely with Vince Smeraglia, director of UMDNJ's Office of Technology Transfer and Business Development, to invest exclusively in research at UMDNJ by funding new life science companies. The article quotes Smeraglia and FVCG president James Golubieski. The two explain the wisdom behind creating a venture capital fund using endowments and describe the risks and rewards of investing in early-stage technologies.

10-18-11
The UMDNJ Office of Technology Transfer and Business Development (formerly the Office of Patents and Licensing) October 2011 Quarterly Newsletter has now published! To read the newsletter and learn more about technology transfer at UMDNJ please click here.

10-11-11
Technology Transfer Faculty Education
Seminar Series

Presents:

What Every Faculty
Member Needs To
Know About Recent
Changes In US
Patent Law
Guest Speakers:
Gerard P. Norton, PhD, Esq and
Peter J. Butch III Esq
Date: Thursday, October 27, 2011
Time: 2:00 pm
Location: MSB, Room B610 (Medical Science
Building / 185 South Orange Avenue / Newark, New Jersey 07101)
** Light refreshments
will be served **
PLEASE RSVP to:
OTTBD@umdnj.edu

09-13-11 Technical Entrepreneurship Seminar Series presents Dr. Reza Razavi, Director, New Ventures and Strategic Initiatives Foundation Venture Capital Group, LLC."Pharmaceutical Research and Biotechnology Development: Industrial & Academic Integration" Thursday, October 6, 2011, 5:00 - 6:00 PM, Busch Campus, Rutgers University, Biomedical Engineering building, Room 102. To RSVP, contact Susan Engelhardt, Center for Innovative Ventures of Emerging Technologies (CIVET), 732-445-4500 x6283 engels@rci.rutgers.edu. Or respond via at: http://www.evite.com/app
/publicUrl/OAEEQWAKYF
AINXKQPHXG/RU-Razavi. Visit us at http://www.civet.rutgers.edu.

09-07-11 The UMDNJ Office of Technology Transfer and Business Development will support the cost of poster submission ($150) for select abstracts! Please contact the OTTBD (OTTBD@umdnj.edu) for additional information.

Submit Your Research Define Your Future at Biotech 2011 October 24-25 | Philadelphia, PA The Biotech 2011 Innovation Corridor provides a unique opportunity for you to share your research with top industry leaders from the region's bioscience industry. This is your chance to have your research reviewed and critiqued by leading bioscience experts. The objective of this session is to foster world-class collaborations among academia, early-stage research organizations, and industry. The Innovation Corridor is being held on Tuesday, October 25th The abstract submission deadline is September 13th Poster presenters can attend the meeting at a significantly reduced price!

Patent Award and Issuance News

11-7-07 - Thomas Alva Edison Patent Awards Dinner tonight in Basking Ridge

(the following article is copied from UMDNJ's News and Events page:)

NEWARK - Researchers from the UMDNJ-Robert Wood Johnson Medical School, the UMDNJ-New Jersey Medical School and the New Jersey Institute for Technology (NJIT) are among the winners of this years Thomas Alva Edison Patent of the Year Awards presented by the Research and Development Council of New Jersey. The researchers will be honored at the councils annual awards dinner on Wednesday, Nov. 7, in Basking Ridge.

Dr. Kiran Chada, of the Department of Biochemistry at the UMDNJ-Robert Wood Johnson Medical School, led a team of researchers who are receiving the Edison Award in the Technology Transfer category for their patent of HMGI Proteins in Cancer. The patent involves a method for identifying a specific cancer biomarker in the blood, which, in turn, can determine the level to which the cancer has advanced in the patient. Other members of Dr. Chadas research team who will share in the award are Dr. Hena Ashar, Dr. Alex Tkachenko and Dr. Xianjin Zhou.

Dr. Peter Tolias, of the Department of Pediatrics and executive director of the Institute of Genomic Medicine at the UMDNJ-New Jersey Medical School, and Dr. Timothy Chang, a professor of Electrical and Computer Engineering at the New Jersey Institute of Technology, are receiving an Edison Award in the Enabling Technologies category for their patent of Delivery of Metered Amounts of Liquid Materials. Their patent provides a new liquid dispensing/aspirating system capable of producing tiny droplets of a substance for research and analysis. The initial application of the patent is focused on DNA microarray fabrication. Among its potential applications, the invention could significantly impact the healthcare research infrastructure by offering low cost, reliable and high throughput genetic analysis and screening for disease and drug identification.

The Research and Development Council of New Jersey is a non-profit association dedicated to cultivating an environment supportive of the advancement of research and development throughout New Jersey. The Thomas Alva Edison Patent Awards commemorate the inventive spirit of the man who received more U.S. patents than any other single person and are presented annually to recognize and encourage the technological creativity and leadership of New Jerseys research and development community.

The University of Medicine and Dentistry of New Jersey (UMDNJ) is the nation's largest free-standing public health sciences university with more than 5,500 students attending the state's three medical schools, its only dental school, a graduate school of biomedical sciences, a school of health related professions, a school of nursing and its only school of public health, on five campuses. Last year, there were more than two million patient visits to UMDNJ facilities and faculty at campuses in Newark, New Brunswick/Piscataway, Scotch Plains, Camden and Stratford. UMDNJ operates University Hospital, a Level I Trauma Center in Newark, and University Behavioral HealthCare, a mental health and addiction services network.